(Total Views: 402)
Posted On: 10/03/2025 9:07:30 AM
Post# of 157687
Re: papplesnap1 #157577
AI Overview
Canada does not have a "Right to Try" law, but it uses the Special Access Programme (SAP) to provide access to drugs not yet available in Canada for serious or life-threatening conditions when conventional treatments have failed. The program is for a healthcare professional to request a drug on behalf of a patient, with approval contingent on the need being legitimate, a qualified physician's involvement, and the drug manufacturer's agreement to supply it.
How the Special Access Programme (SAP) Works
Request Initiation: A healthcare professional (like a doctor) initiates the request to Health Canada.
Patient Condition: The request is for a patient with a serious or life-threatening condition.
Failed Treatments: Conventional treatments for the patient's condition have failed, are unsuitable, or are unavailable.
Drug Status: The drug is not authorized for sale in Canada.
Health Canada Review: Health Canada reviews the request to ensure the need is legitimate and there is sufficient evidence for the requested use.
Manufacturer Agreement: The manufacturer of the drug must agree to release the product for the specified patient.
Authorization: If all conditions are met, Health Canada authorizes the manufacturer to sell the drug to the qualified physician for use with the patient.
Canada does not have a "Right to Try" law, but it uses the Special Access Programme (SAP) to provide access to drugs not yet available in Canada for serious or life-threatening conditions when conventional treatments have failed. The program is for a healthcare professional to request a drug on behalf of a patient, with approval contingent on the need being legitimate, a qualified physician's involvement, and the drug manufacturer's agreement to supply it.
How the Special Access Programme (SAP) Works
Request Initiation: A healthcare professional (like a doctor) initiates the request to Health Canada.
Patient Condition: The request is for a patient with a serious or life-threatening condition.
Failed Treatments: Conventional treatments for the patient's condition have failed, are unsuitable, or are unavailable.
Drug Status: The drug is not authorized for sale in Canada.
Health Canada Review: Health Canada reviews the request to ensure the need is legitimate and there is sufficient evidence for the requested use.
Manufacturer Agreement: The manufacturer of the drug must agree to release the product for the specified patient.
Authorization: If all conditions are met, Health Canada authorizes the manufacturer to sell the drug to the qualified physician for use with the patient.
(7)
(0)
